Jay Pepose serves as Executive at Ocuphire Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Jay Pepose has executed 10 insider transactions totaling $90.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 11, 2024 involved receiving (via award) 41,143 shares valued at $0.
Jay Pepose currently holds 180,458 shares of Ocuphire Pharma, Inc. (OCUP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jay Pepose has been a net buyer of OCUP stock. They have purchased $90.1K and sold $0 worth of shares.
Jay Pepose's most recent insider trade was on Jun 11, 2024, when they sold 41,143 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 1, 2024 | OCUP | $0 | Award | 14,964 | $N/A | Discretionary |
| Nov 1, 2023 | OCUP | $0 | Award | 35,000 | $N/A | Discretionary |
| Jun 6, 2023 | OCUP | $0 | Award | 10,976 | $N/A | Discretionary |
| Apr 19, 2023 | OCUP | $0 | Award | 468 | $N/A | Discretionary |
| Jan 11, 2023 | OCUP | $0 | Award | 13,013 | $N/A | Discretionary |
| Jul 1, 2022 | OCUP | $0 | Award | 9,900 | $N/A | Discretionary |
| Dec 13, 2021 | OCUP | $30.1K | Purchase | 8,250 | $3.65 | Discretionary |
| Sep 13, 2021 | OCUP | $60.0K | Purchase | 12,631 | $4.75 | Discretionary |